/ PORTFOLIO
conforma-1024x492

San Diego, CA

Conforma Therapeutics discovered and developed drugs that inhibit heat shock protein 90 (HSP90) molecules, which are involved in protecting and supporting the growth of cancer cells across a range of tumor types, and which also play a role in tumor resistance to a number of cancer therapies.

Acquired by Biogen in May 2006.

logo-rivervest

© Copyright RiverVest® All Rights Reserved.